Denis V. Shaduro
Denis V. Shaduro has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Vladimir A. Beloglazov
S. Georgievsky Medical Institute, V. Vernadsky Crimean Federal University
6 shared publications - Andrey V. Petrov
Vernadsky Crimean Federal University
2 shared publications Array И. Гордиенко
Медицинская академия им. С.И. Георгиевского ФГАОУ ВО «Крымский федеральный университет им. В.И. Вернадского
2 shared publications- Eugene D. Kumelskiy
V.I. Vernadsky Crimean Federal University
2 shared publications - Igor A. Yatskov
S. Georgievsky Medical Institute, V. Vernadsky Crimean Federal University
2 shared publications A V Petrov
1 shared publication
Latest Publications
- 24 September 2025
- Published by Media Sphere Publishing Group in Problems of Balneology, Physiotherapy and Exercise Therapy
- Vol. 102 (4) , 14-19
The use of grape polyphenols in combination with magnetic therapy in patients with bronchial asthma who have suffered a new coronavirus infection
Many patients who have suffered from SARS-CoV-2 infection (new coronavirus infection, NCI) face long-term consequences affecting the respiratory, cardiovascular and nervous systems, as well as the appearance of new symptoms that are not characteristic of their previous health condition. Studies indicate that patients who have undergone NCI are at risk of developing thrombotic disorders and problems with the cardiovascular system due to the presence of a low-grade inflammatory process (LGI). In this regard, there is a need to develop new methods and tools, including non-pharmacological approaches, to combat LGI. Objective. To evaluate the effect of grape polyphenols and magnetic therapy on the state of the LGI in patients with asthma who have undergone COVID-19. Material and methods. The study included patients with a verified diagnosis of asthma, as well as a history of NCI and with manifestations of postcovid syndrome living in the Republic of Crimea. Patients (n=50) according to indications, namely the presence of manifestations of postcovid syndrome, were referred for sanatorium treatment to the Department of Pulmonology of the Sechenov Institute in Yalta. The intervention group (n=20), in addition to standard sanatorium treatment, received a concentrate of polyphenols of Fenokor grapes produced by Resfood LLC, as well as a course of low-intensity magnetic therapy (MT) using a low-frequency magnetic therapy unit with frequency control of UMTvp-MADIN Lux (Magnetoturbotron), Russia. The second group was a control group, and consisted of 30 patients who were comparable in gender and age to the experimental group. ELISA kits manufactured by Cloud Clone Corp. were used to determine the level of C-reactive protein (CRP), zonulin, lipopolysaccharide (LPS), sCD14, LPS-binding protein, and bactericidal protein that increases bacterial permeability (BPI). (Wuhan, Hubei, China). Results. In patients of group 1, after a course of sanatorium treatment with the use of polyphenol concentrate and MT, a significant decrease in the level of CRP was revealed (p<0.011). In both groups, a statistically significant increase in the concentration of BPI, sCD14 and zonulin was registered (p0.05). Conclusions. The use of grape polyphenol concentrates in combination with MT helps to reduce the level of C-reactive protein and increase the activity of components of LPS-binding systems in humans during the recovery period after COVID-19. However, sanatorium treatment can contribute to stress and changes in intestinal permeability, which requires additional research to understand its effect on the enterohematic barrier and protection against excessive translocation of bacterial components from the intestine into the blood.
- 24 September 2025
- Published by Media Sphere Publishing Group in Problems of Balneology, Physiotherapy and Exercise Therapy
- Vol. 102 (4) , 14-19
The use of grape polyphenols in combination with magnetic therapy in patients with bronchial asthma who have suffered a new coronavirus infection
Many patients who have suffered from SARS-CoV-2 infection (new coronavirus infection, NCI) face long-term consequences affecting the respiratory, cardiovascular and nervous systems, as well as the appearance of new symptoms that are not characteristic of their previous health condition. Studies indicate that patients who have undergone NCI are at risk of developing thrombotic disorders and problems with the cardiovascular system due to the presence of a low-grade inflammatory process (LGI). In this regard, there is a need to develop new methods and tools, including non-pharmacological approaches, to combat LGI. Objective. To evaluate the effect of grape polyphenols and magnetic therapy on the state of the LGI in patients with asthma who have undergone COVID-19. Material and methods. The study included patients with a verified diagnosis of asthma, as well as a history of NCI and with manifestations of postcovid syndrome living in the Republic of Crimea. Patients (n=50) according to indications, namely the presence of manifestations of postcovid syndrome, were referred for sanatorium treatment to the Department of Pulmonology of the Sechenov Institute in Yalta. The intervention group (n=20), in addition to standard sanatorium treatment, received a concentrate of polyphenols of Fenokor grapes produced by Resfood LLC, as well as a course of low-intensity magnetic therapy (MT) using a low-frequency magnetic therapy unit with frequency control of UMTvp-MADIN Lux (Magnetoturbotron), Russia. The second group was a control group, and consisted of 30 patients who were comparable in gender and age to the experimental group. ELISA kits manufactured by Cloud Clone Corp. were used to determine the level of C-reactive protein (CRP), zonulin, lipopolysaccharide (LPS), sCD14, LPS-binding protein, and bactericidal protein that increases bacterial permeability (BPI). (Wuhan, Hubei, China). Results. In patients of group 1, after a course of sanatorium treatment with the use of polyphenol concentrate and MT, a significant decrease in the level of CRP was revealed (p<0.011). In both groups, a statistically significant increase in the concentration of BPI, sCD14 and zonulin was registered (p0.05). Conclusions. The use of grape polyphenol concentrates in combination with MT helps to reduce the level of C-reactive protein and increase the activity of components of LPS-binding systems in humans during the recovery period after COVID-19. However, sanatorium treatment can contribute to stress and changes in intestinal permeability, which requires additional research to understand its effect on the enterohematic barrier and protection against excessive translocation of bacterial components from the intestine into the blood.
- Open Access
- 21 September 2025
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 97,p. 91-101
Application of dry carbon dioxide baths and magnetotherapy in the treatment of patients during the post COVID period
Aim. To study the effect of dry carbon dioxide baths (DCB) and magnetotherapy (MT) on quality-oflife indicators, dyspnoea severity, psychological status and systemic inflammation in patients who had recovered from novel coronavirus infection (NCI).Materials and methods. Patients with a history of NCI were divided into two groups. Group 1 (n = 20) received a course of DCB; Group 2 (n = 20) received a course of MT. A control group (n = 20) comprised relatively healthy individuals with no history of NCI (absence of anti-SARS-CoV-2 S-protein IgG at enrolment), matched by sex and age with the study groups. At baseline — all participants — and after treatment — patients in Groups 1 and 2 — completed questionnaires assessing quality of life, anxiety level and severity of respiratory symptoms (SF-36, HADS, mMRC, Borg scale). Blood plasma was collected to determine C-reactive protein (CRP) by ELISA (Cloud Clone Corp., Wuhan, Hubei, China).Results. Post-COVID patients had lower quality-of-life scores and higher levels of anxiety, depression, dyspnoea and exercise intolerance than controls. Both DCB and MT improved quality-of-life scores and reduced anxiety, depression, dyspnoea and exercise-induced symptom burden in post-COVID patients compared with the control group. According to SF-36, mean total quality of life increased by 9.3% in Group 1 and by 4.55% in Group 2. On the HADS scale, anxiety fell by 16.3% and depression by 19.0% in Group 1; by 8.6% and 14.3%, respectively, in Group 2. In Group 1 the mMRC dyspnoea score decreased by 55%, and the Borg score by 50%; in Group 2 by 35% and 22.5%, respectively. DCB also significantly lowered CRP (p < 0.001) from 1.12 [0.42; 1.81] mg/mL before treatment to 0.91 [0.26; 1.57] mg/mL afterwards.Conclusion. Dry carbon dioxide baths and magnetotherapy appear to be promising approaches for mitigating manifestations of post COVID syndrome, but their efficacy should be confirmed in larger studies.
- 21 September 2025
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 97,p. 91-101
Open AccessApplication of dry carbon dioxide baths and magnetotherapy in the treatment of patients during the post COVID period
Aim. To study the effect of dry carbon dioxide baths (DCB) and magnetotherapy (MT) on quality-oflife indicators, dyspnoea severity, psychological status and systemic inflammation in patients who had recovered from novel coronavirus infection (NCI).Materials and methods. Patients with a history of NCI were divided into two groups. Group 1 (n = 20) received a course of DCB; Group 2 (n = 20) received a course of MT. A control group (n = 20) comprised relatively healthy individuals with no history of NCI (absence of anti-SARS-CoV-2 S-protein IgG at enrolment), matched by sex and age with the study groups. At baseline — all participants — and after treatment — patients in Groups 1 and 2 — completed questionnaires assessing quality of life, anxiety level and severity of respiratory symptoms (SF-36, HADS, mMRC, Borg scale). Blood plasma was collected to determine C-reactive protein (CRP) by ELISA (Cloud Clone Corp., Wuhan, Hubei, China).Results. Post-COVID patients had lower quality-of-life scores and higher levels of anxiety, depression, dyspnoea and exercise intolerance than controls. Both DCB and MT improved quality-of-life scores and reduced anxiety, depression, dyspnoea and exercise-induced symptom burden in post-COVID patients compared with the control group. According to SF-36, mean total quality of life increased by 9.3% in Group 1 and by 4.55% in Group 2. On the HADS scale, anxiety fell by 16.3% and depression by 19.0% in Group 1; by 8.6% and 14.3%, respectively, in Group 2. In Group 1 the mMRC dyspnoea score decreased by 55%, and the Borg score by 50%; in Group 2 by 35% and 22.5%, respectively. DCB also significantly lowered CRP (p < 0.001) from 1.12 [0.42; 1.81] mg/mL before treatment to 0.91 [0.26; 1.57] mg/mL afterwards.Conclusion. Dry carbon dioxide baths and magnetotherapy appear to be promising approaches for mitigating manifestations of post COVID syndrome, but their efficacy should be confirmed in larger studies.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 18 (4) , 373-379
Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report
Background: Cryopyrin-Associated Periodic Syndrome (CAPS) is a variety of clinical variants of autoinflammatory diseases. The pathology is based on a mutation in the NLRP3 gene encoding the cryopyrin protein, which leads to the uncontrolled production of interleukin-1β. Particular attention should be paid to the rarity of this disease and the lack of clinical knowledge about it in therapeutic and rheumatological practice, which leads to an erroneous diagnosis and the appointment of ineffective treatment for a long time, leading to the progression of the disease and disability of the patient. Case Presentation: This article describes a clinical case of this disease. The first manifestations of the disease in a woman appeared from the age of 2 years, in the form of a rash and fever. Since school age, there have been signs of arthritis. By the age of 24, sensorineural hearing loss and pain in the spine were evident. The disease occurred under the clinical manifestations of spondyloarthritis. Its treatment with anti-inflammatory therapy did not give a stable result. Conclusion: From the analysis, we can conclude that patient M. from early childhood suffers from a severe Neonatal-onset Multisystem Inflammatory Disease of a genetic nature. For a long time, the patient was diagnosed with ankylosing spondylitis, and appropriate treatment was carried out without significant success. The correct diagnosis of CAPS was made only in 2018. This patient has conditions of both CAPS and AS together, which is a very rare association in rheumatological practice. The only treatment method that could stop the manifestations of the disease and prevent life-threatening kidney damage (amyloidosis) is the use of genetically engineered biological drugs, i.e., IL-1β inhibitors. The only drug of this group registered in Russia is canakinumab (Ilaris®). From the moment of diagnosis to the present day, the patient is treated with the genetically engineered drug canakinumab (Ilaris®) at a dose of 150 mg once every 8 weeks. 6 months after taking the drug, the patient went into complete clinical and laboratory remission.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 18 (4) , 373-379
Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report
Background: Cryopyrin-Associated Periodic Syndrome (CAPS) is a variety of clinical variants of autoinflammatory diseases. The pathology is based on a mutation in the NLRP3 gene encoding the cryopyrin protein, which leads to the uncontrolled production of interleukin-1β. Particular attention should be paid to the rarity of this disease and the lack of clinical knowledge about it in therapeutic and rheumatological practice, which leads to an erroneous diagnosis and the appointment of ineffective treatment for a long time, leading to the progression of the disease and disability of the patient. Case Presentation: This article describes a clinical case of this disease. The first manifestations of the disease in a woman appeared from the age of 2 years, in the form of a rash and fever. Since school age, there have been signs of arthritis. By the age of 24, sensorineural hearing loss and pain in the spine were evident. The disease occurred under the clinical manifestations of spondyloarthritis. Its treatment with anti-inflammatory therapy did not give a stable result. Conclusion: From the analysis, we can conclude that patient M. from early childhood suffers from a severe Neonatal-onset Multisystem Inflammatory Disease of a genetic nature. For a long time, the patient was diagnosed with ankylosing spondylitis, and appropriate treatment was carried out without significant success. The correct diagnosis of CAPS was made only in 2018. This patient has conditions of both CAPS and AS together, which is a very rare association in rheumatological practice. The only treatment method that could stop the manifestations of the disease and prevent life-threatening kidney damage (amyloidosis) is the use of genetically engineered biological drugs, i.e., IL-1β inhibitors. The only drug of this group registered in Russia is canakinumab (Ilaris®). From the moment of diagnosis to the present day, the patient is treated with the genetically engineered drug canakinumab (Ilaris®) at a dose of 150 mg once every 8 weeks. 6 months after taking the drug, the patient went into complete clinical and laboratory remission.
- Open Access
- 21 April 2017
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 95 (2)
Modern clinical and epidemiological characteristic of systemic lupus erythematosus based on the data of the territorial registry
Systemic lupus erythematosus (SLE) is a severe rheumatic disease characterized by polysymptomatic clinical picture. At the present stage, there are no updated epidemiological data due to the low prevalence of the disease. The aim of the study was to examine the current clinical and epidemiological characteristics of patients with systemic lupus erythematosus based on the information contained in the territorial register, analysis of occurrence and symptoms at the early stage of the disease. This study demonstrated the epidemiological and clinical characteristics of SLE from the analysis of 107 cases during the period from 2011 to 2013 and retrospective analysis of the cases for 1980-2013. The epidemiological situation was evaluated based on extensive and intensive indicators using statistical software license. The current SLE prevalence was estimated at 5,59 per 100 000 population in 2013, the incidence between 1994 and 2003 at 0,29 per 100 000 population and between 2004 and 2013 at 0,49, with the peak in 2010 up to 1,35 per 100 000 population. The average absolute growth and growth rate of SLE in the first decade was 0,05% and 0,24%, in the second decade 0,001% and 0,006% respectively, with the female to male ratio being 9:1, mean age of the patients 37,62±11,65 years), and ethnic composition of 87 Slavs and 15 Crimean Tatars. The most common symptoms at the early (polyarthritis, fever, dermatitis) and advanced (polyarthritis, Raynaud's syndrome, carditis, myalgia) stages differed from those specified by American College of Rheumatology (1997). The difference between early and late symptoms of SLE was documented . Based on the data obtained, the division of the disease into clinical subtypes (phenotypes) is proposed.
- 21 April 2017
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 95 (2)
Open AccessModern clinical and epidemiological characteristic of systemic lupus erythematosus based on the data of the territorial registry
Systemic lupus erythematosus (SLE) is a severe rheumatic disease characterized by polysymptomatic clinical picture. At the present stage, there are no updated epidemiological data due to the low prevalence of the disease. The aim of the study was to examine the current clinical and epidemiological characteristics of patients with systemic lupus erythematosus based on the information contained in the territorial register, analysis of occurrence and symptoms at the early stage of the disease. This study demonstrated the epidemiological and clinical characteristics of SLE from the analysis of 107 cases during the period from 2011 to 2013 and retrospective analysis of the cases for 1980-2013. The epidemiological situation was evaluated based on extensive and intensive indicators using statistical software license. The current SLE prevalence was estimated at 5,59 per 100 000 population in 2013, the incidence between 1994 and 2003 at 0,29 per 100 000 population and between 2004 and 2013 at 0,49, with the peak in 2010 up to 1,35 per 100 000 population. The average absolute growth and growth rate of SLE in the first decade was 0,05% and 0,24%, in the second decade 0,001% and 0,006% respectively, with the female to male ratio being 9:1, mean age of the patients 37,62±11,65 years), and ethnic composition of 87 Slavs and 15 Crimean Tatars. The most common symptoms at the early (polyarthritis, fever, dermatitis) and advanced (polyarthritis, Raynaud's syndrome, carditis, myalgia) stages differed from those specified by American College of Rheumatology (1997). The difference between early and late symptoms of SLE was documented . Based on the data obtained, the division of the disease into clinical subtypes (phenotypes) is proposed.
- 1 January 2017
- Vol. 95 (2) , 140-7
[MODERN CLINICAL EPIDEMIOLOGICAL CHARACTERISTIC OF LUPUS ERYTHEMATOSUS BASED ON THE DATA OF REGIONAL REGISTRY].
Systemic lupus erythematosus (SLE) is a severe rheumatic disease characterized by polysymptomatic clinical picture. At the present stage, there are no updated epidemiological data due to the low prevalence of the disease. The aim of the study was to examine the current clinical and epidemiological characteristics of patients with systemic lupus erythematosus based on the information contained in the territorial register, analysis of occurrence and symptoms at the early stage of the disease. This study demonstrated the epidemiological and clinical characteristics of SLE from the analysis of 107 cases during the period from 2011 to 2013 and retrospective analysis of the cases for 1980-2013. The epidemiological situation was evaluated based on extensive and intensive indicators using statistical software license. The current SLE prevalence was estimated at 5,59 per 100 000 population in 2013, the incidence between 1994 and 2003 at 0,29 per 100 000 population and between 2004 and 2013 at 0,49, with the peak in 2010 up to 1,35 per 100 000 population. The average absolute growth and growth rate of SLE in the first decade was 0,05% and 0,24%, in the second decade 0,001% and 0,006% respectively, with the female to male ratio being 9:1, mean age of the patients 37,62±11,65 years), and ethnic composition of 87 Slavs and 15 Crimean Tatars. The most common symptoms at the early (polyarthritis, fever, dermatitis) and advanced (polyarthritis, Raynaud's syndrome, carditis, myalgia) stages differed from those specified by American College of Rheumatology (1997). The difference between early and late symptoms of SLE was documented . Based on the data obtained, the division of the disease into clinical subtypes (phenotypes) is proposed.
- 1 January 2017
- Vol. 95 (2) , 140-7
[MODERN CLINICAL EPIDEMIOLOGICAL CHARACTERISTIC OF LUPUS ERYTHEMATOSUS BASED ON THE DATA OF REGIONAL REGISTRY].
Systemic lupus erythematosus (SLE) is a severe rheumatic disease characterized by polysymptomatic clinical picture. At the present stage, there are no updated epidemiological data due to the low prevalence of the disease. The aim of the study was to examine the current clinical and epidemiological characteristics of patients with systemic lupus erythematosus based on the information contained in the territorial register, analysis of occurrence and symptoms at the early stage of the disease. This study demonstrated the epidemiological and clinical characteristics of SLE from the analysis of 107 cases during the period from 2011 to 2013 and retrospective analysis of the cases for 1980-2013. The epidemiological situation was evaluated based on extensive and intensive indicators using statistical software license. The current SLE prevalence was estimated at 5,59 per 100 000 population in 2013, the incidence between 1994 and 2003 at 0,29 per 100 000 population and between 2004 and 2013 at 0,49, with the peak in 2010 up to 1,35 per 100 000 population. The average absolute growth and growth rate of SLE in the first decade was 0,05% and 0,24%, in the second decade 0,001% and 0,006% respectively, with the female to male ratio being 9:1, mean age of the patients 37,62±11,65 years), and ethnic composition of 87 Slavs and 15 Crimean Tatars. The most common symptoms at the early (polyarthritis, fever, dermatitis) and advanced (polyarthritis, Raynaud's syndrome, carditis, myalgia) stages differed from those specified by American College of Rheumatology (1997). The difference between early and late symptoms of SLE was documented . Based on the data obtained, the division of the disease into clinical subtypes (phenotypes) is proposed.
- 1 November 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (5) , S75
P179 Epidemiological characteristics of systemic lupus erythematosus in crimea, a subtropical multiethnic region
- 1 November 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (5) , S75
P179 Epidemiological characteristics of systemic lupus erythematosus in crimea, a subtropical multiethnic region
- Open Access
- 24 June 2016
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 6 (2) , 165-172
THE INFLUENCE OF HUMORAL IMMUNITY ANTIENDOTOXIN RESPONSE TO INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Введение. Системная красная волчанка (СКВ) — тяжелое аутоиммунное заболевание с высоким уровнем инвалидизации и летальности. С каждым десятилетием уровень заболеваемости СВК возрастает. Современные исследования не позволяют выявить этиологию данного заболевания. В патогенетической картине заболевания преобладают процессы поликлональной стимуляции Т- и В-лимфоцитов. В качестве одного из мощных триггеров может выступать липополисахарид (ЛПС), или эндотоксин (ЭТ), грамнегативных бактерий. Активность воздействия которого регулируется специфическим гуморальным и клеточным антиэндотоксиновым ответом иммунитета. Материалы и методы. В исследовании участвовало 48 больных СКВ, контрольную группу составили 40 относительно здоровых доноров. Материалом исследования послужила венозная кровь. Были определены следующие показатели: уровни специфических антиэндотоксиновых антител (анти-ЛПС-IgA, IgM и IgG ) — методом твердофазного иммуноферментного анализа (тИФА); концентрация общих иммуноглобулинов IgA, IgM и IgG — микротурбидиметрическим методом; концентрация С-реактивного белка (СРБ) — «сэндвич»-вариантом тИФА; эндогенная интоксикация (ЭИ) — методом определения молекул средней массы по спектру поглощения в ультрафиолете; циркулирующие иммунные комплексы (ЦИК) — методом преципитации в полиэтиленгликоле. Статистическую обработку проводили при помощи лицензионного программного обеспечения Microsoft Office Excel 2007 и MedStat®. Результаты. В ходе исследования было выявлено статистически значимое увеличение анти-ЛПС-IgG у больных СКВ в 2,5 раза по сравнению с контрольной группой, незначительное увеличение общего IgG на 5%. Индекс эндогенной интоксикации у больных СКВ был выше на 13,9%, ЦИК — на 150%. Уровень СРБ в группе исследования был увеличен в 6,8 раз по сравнению с контролем. Также были выявлены: обратная корреляционная связь между анти-ЛПС-IgG и СРБ и между анти-ЛПС- IgG и ЭИ, прямая корреляционная связь между анти-ЛПС-IgA и возрастом больных. Обсуждение. Полученные результаты свидетельствуют о дисфункции антиэндотоксинового иммунного ответа (АЭО) у больных СКВ, а именно об увеличении концентрации специфических анти-ЛПС-Ig. Выявленные увеличения показателей системного воспаления коррелировали с показателями АЭО, что подтверждает их взаимное влияние, что способствует поражению органов мишеней и может усугублять проявление и течение СКВ. Нормализация АЭО и элиминация ЛПС может стать новым направлением терапии больных СКВ.
- 24 June 2016
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 6 (2) , 165-172
Open AccessTHE INFLUENCE OF HUMORAL IMMUNITY ANTIENDOTOXIN RESPONSE TO INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Введение. Системная красная волчанка (СКВ) — тяжелое аутоиммунное заболевание с высоким уровнем инвалидизации и летальности. С каждым десятилетием уровень заболеваемости СВК возрастает. Современные исследования не позволяют выявить этиологию данного заболевания. В патогенетической картине заболевания преобладают процессы поликлональной стимуляции Т- и В-лимфоцитов. В качестве одного из мощных триггеров может выступать липополисахарид (ЛПС), или эндотоксин (ЭТ), грамнегативных бактерий. Активность воздействия которого регулируется специфическим гуморальным и клеточным антиэндотоксиновым ответом иммунитета. Материалы и методы. В исследовании участвовало 48 больных СКВ, контрольную группу составили 40 относительно здоровых доноров. Материалом исследования послужила венозная кровь. Были определены следующие показатели: уровни специфических антиэндотоксиновых антител (анти-ЛПС-IgA, IgM и IgG ) — методом твердофазного иммуноферментного анализа (тИФА); концентрация общих иммуноглобулинов IgA, IgM и IgG — микротурбидиметрическим методом; концентрация С-реактивного белка (СРБ) — «сэндвич»-вариантом тИФА; эндогенная интоксикация (ЭИ) — методом определения молекул средней массы по спектру поглощения в ультрафиолете; циркулирующие иммунные комплексы (ЦИК) — методом преципитации в полиэтиленгликоле. Статистическую обработку проводили при помощи лицензионного программного обеспечения Microsoft Office Excel 2007 и MedStat®. Результаты. В ходе исследования было выявлено статистически значимое увеличение анти-ЛПС-IgG у больных СКВ в 2,5 раза по сравнению с контрольной группой, незначительное увеличение общего IgG на 5%. Индекс эндогенной интоксикации у больных СКВ был выше на 13,9%, ЦИК — на 150%. Уровень СРБ в группе исследования был увеличен в 6,8 раз по сравнению с контролем. Также были выявлены: обратная корреляционная связь между анти-ЛПС-IgG и СРБ и между анти-ЛПС- IgG и ЭИ, прямая корреляционная связь между анти-ЛПС-IgA и возрастом больных. Обсуждение. Полученные результаты свидетельствуют о дисфункции антиэндотоксинового иммунного ответа (АЭО) у больных СКВ, а именно об увеличении концентрации специфических анти-ЛПС-Ig. Выявленные увеличения показателей системного воспаления коррелировали с показателями АЭО, что подтверждает их взаимное влияние, что способствует поражению органов мишеней и может усугублять проявление и течение СКВ. Нормализация АЭО и элиминация ЛПС может стать новым направлением терапии больных СКВ.
- Open Access
- 7 October 2015
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 17 (4) , 359-366
MAJOR LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR ASSOCIATIONS WITH CELLULAR AND HUMORAL ANTI-ENDOTOXIN IMMUNITY
Системная красная волчанка на современном этапе занимает ведущее место среди системных аутоиммунных патологий. Несмотря на существенный прогресс в понимании основных звеньев патогенеза системной красной волчанки, многие аспекты субтильных механизмов прогрессирования волчаночного воспаления по-прежнему остаются неизвестными. На роль персистентных факторов самоподдержания аутоиммунного воспаления может претендовать липополисахарид или эндотоксин граммнегативных кишечных бактерий. Цель работы заключалась в изучении уровней основных субпопуляций лимфоцитов, их возможной связи со специфическими антиэндотоксиновыми анти-телами и эндотоксин-нейтрализующими рецепторами гранулоцитов и моноцитов периферической крови больных системной красной волчанкой. В исследовании участвовало 48 больных СКВ. Методами проточной цитофлуорометрии и иммуноферментного анализа был определен уровень субпопуляций лимфоцитов, уровни экспрессии антиэндотоксиновых рецепторов на моноцитах и гранулоцитах, а также уровни общих и антиэндотоксиновых иммуноглобулинов. В ходе исследования нами выявлено увеличение уровня общих, активированных и цитотоксических Т-лимфоцитов, снижение В-лимфоцитов и NK-клеток, снижение эндотоксин-связывающих рецепторов на моноцитах и гранулоцитах, увеличение антиэндотоксиновых антител класса G. Выявлены корреляционные связи между уровнем эндотоксин-связывающих рецепторов на лейкоцитах и уровнем В-лимфоцитов, антиэндотоксиновых антител класса М с уровнем В-лимфоцитов и цитотоксических Т-лимфоцитов, антиэндотоксиновых антител класса G с уровнем CD4+ лимфоцитов. Существенные нарушения в состоянии антиэндотоксинового иммунитета у больных СКВ свидетельствуют, что данный дисбаланс может играть важную роль в механизмах формирования и прогрессирования аутоиммунной патологии.
- 7 October 2015
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 17 (4) , 359-366
Open AccessMAJOR LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR ASSOCIATIONS WITH CELLULAR AND HUMORAL ANTI-ENDOTOXIN IMMUNITY
Системная красная волчанка на современном этапе занимает ведущее место среди системных аутоиммунных патологий. Несмотря на существенный прогресс в понимании основных звеньев патогенеза системной красной волчанки, многие аспекты субтильных механизмов прогрессирования волчаночного воспаления по-прежнему остаются неизвестными. На роль персистентных факторов самоподдержания аутоиммунного воспаления может претендовать липополисахарид или эндотоксин граммнегативных кишечных бактерий. Цель работы заключалась в изучении уровней основных субпопуляций лимфоцитов, их возможной связи со специфическими антиэндотоксиновыми анти-телами и эндотоксин-нейтрализующими рецепторами гранулоцитов и моноцитов периферической крови больных системной красной волчанкой. В исследовании участвовало 48 больных СКВ. Методами проточной цитофлуорометрии и иммуноферментного анализа был определен уровень субпопуляций лимфоцитов, уровни экспрессии антиэндотоксиновых рецепторов на моноцитах и гранулоцитах, а также уровни общих и антиэндотоксиновых иммуноглобулинов. В ходе исследования нами выявлено увеличение уровня общих, активированных и цитотоксических Т-лимфоцитов, снижение В-лимфоцитов и NK-клеток, снижение эндотоксин-связывающих рецепторов на моноцитах и гранулоцитах, увеличение антиэндотоксиновых антител класса G. Выявлены корреляционные связи между уровнем эндотоксин-связывающих рецепторов на лейкоцитах и уровнем В-лимфоцитов, антиэндотоксиновых антител класса М с уровнем В-лимфоцитов и цитотоксических Т-лимфоцитов, антиэндотоксиновых антител класса G с уровнем CD4+ лимфоцитов. Существенные нарушения в состоянии антиэндотоксинового иммунитета у больных СКВ свидетельствуют, что данный дисбаланс может играть важную роль в механизмах формирования и прогрессирования аутоиммунной патологии.